Dear colleagues,

The contraceptive implant is a highly effective, safe, and long-acting contraceptive method that has been shown to be acceptable to women worldwide. However, the high cost of this commodity has been a major barrier to its availability in many countries. Sino-implant (II), a low-cost and highly effective implant, is substantially less expensive than other alternatives on the market. FHI leads an effort to ensure the safe and sustainable introduction of Sino-implant (II) in resource-constrained countries in coordination with the manufacturer, distributors, donors and other partners. The August 2010 edition of the quarterly newsletter includes information about quality assurance, product registration, current research, resources and more. You can access the newsletter at http://www.fhi.org/en/Research/Projects/res_Sino_Update_1.htm.

For additional information, please email [log in to unmask]<mailto:[log in to unmask]>

The FHI Sino-implant (II) team

To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php